IP Library Assignment 062287/0670
Patent Assignment
Reel/Frame 062287/0670

Assignment of Assignor's Interest

Recorded: 2023-01-05 Pages: 6
Assignor
GLORIANA THERAPEUTICS
Executed: 2022-11-21
Assignee
SINFONIA BIOTHERAPEUTICS AB
HALSOVAGEN 7, HUDDINGE, 14157, SWEDEN
Covered Properties (23)
Novel Neurotrophic Factors
Patent: 6,593,133 →
Application: 09/347,613 →
Novel Neurotrophic Factors
Patent: 6,734,284 →
Application: 09/662,183 →
Polymer Conjugates of Mutated Neublastin
Patent: 7,442,370 →
Application: 10/356,264 →
Publication: US 2005/0142098
Novel Neurotrophic Factors
Patent: 7,276,580 →
Application: 10/661,984 →
Publication: US 2004/0142418
Refolding Transforming Growth Factor Beta Family Proteins
Patent: 8,722,862 →
Application: 11/573,771 →
Publication: US 2008/0249287
Neublastin Variants
Patent: 8,263,553 →
Application: 11/573,773 →
Publication: US 2008/0039385
Methods of Treating Pain Using Neurotrophic Factors
Patent: 7,358,228 →
Application: 11/614,599 →
Publication: US 2007/0099270
Methods of Activating Ret Receptor Tyrosine Kinase Using Neurotrophic Factors
Patent: 7,655,463 →
Application: 12/029,917 →
Publication: US 2008/0233647
Treatments for Neurological Disorders
Application: 12/280,772 →
Publication: US 2009/0221495
Neurotrophic Factors and Methods of Use Thereof
Patent: 8,217,146 →
Application: 12/632,517 →
Publication: US 2010/0292142
Anti-Neublastin Antibodies and Uses Thereof
Application: 12/672,213 →
Publication: US 2011/0135648
Cell Lines and Their Use in Encapsulated Cell Biodelivery
Patent: 8,741,340 →
Application: 13/145,669 →
Publication: US 2012/0027847
Compositions and Methods for Increasing Vascularization
Patent: 9,138,461 →
Application: 13/679,529 →
Publication: US 2013/0237477
Implantable Cell Device with Supportive and Radial Diffusive Scaffolding
Patent: 9,669,154 →
Application: 13/876,088 →
Publication: US 2013/0261543
Stimulation System and Method for Voice Lift
Application: 14/289,956 →
Publication: US 2014/0277272
Cell Lines and Their Use in Encapsulated Cell Biodelivery
Patent: 9,884,023 →
Application: 14/821,498 →
Publication: US 2015/0335587
Implantable Cell Device with Supportive and Radial Diffusive Scaffolding
Application: 15/582,761 →
Publication: US 2017/0232186
Cell Lines and Their Use in Encapsulated Cell Biodelivery
Application: 15/851,741 →
Publication: US 2018/0177736
Implantable Cell Device with Supportive and Radial Diffusive Scaffolding
Application: 17/099,356 →
Publication: US 2021/0069407
Cell Lines and Their Use in Encapsulated Cell Biodelivery
Application: 17/145,877 →
Publication: US 2021/0128482
Mammalian Cell Culture-Produced Neublastin Antibodies
Application: 17/417,067 →
Publication: US 2022/0048984
Therapeutic Protein Formulations
Application: 17/676,085 →
Publication: US 2023/0000988
Mammalian Cells Secreting GDNF and Their Therapeutic Use
Application: 17/789,653 →
Publication: US 2023/0047254
Related Assignments (21)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 14, 2010
From: SAH, DINAH W.Y.; ROSSOMANDO, ANTHONY
To: BIOGEN IDEC MA INC.
Reel/Frame 023784/0518 →
Assignment of Assignor's Interest Jan 14, 2010
From: JOHANSEN, TEIT E.
To: NSGENE A/S
Reel/Frame 023784/0590 →
Assignment of Assignor's Interest Mar 3, 2011
From: ROSSOMANDO, ANTHONY; JIN, PING
To: BIOGEN IDEC MA INC.
Reel/Frame 025897/0812 →
Assignment of Assignor's Interest Nov 17, 2011
From: KUSK, PHILIP; WAHLBERG, LARS ULRIK
To: NSGENE A/S
Reel/Frame 027245/0784 →
Assignment of Assignor's Interest Jun 17, 2013
From: WAHLBERG, LARS ULRIK; TORNOE, JENS
To: NSGENE A/S
Reel/Frame 030624/0358 →
Assignment of Assignor's Interest Sep 17, 2013
From: ROSSOMANDO, ANTHONY
To: BIOGEN IDEC MA INC.
Reel/Frame 031224/0341 →
Assignment of Assignor's Interest Sep 17, 2013
From: SILVESTRE, JEAN-SEBASTIEN; TAMARAT, RADIA
To: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE)
Reel/Frame 031224/0363 →
Assignment of Assignor's Interest May 29, 2014
From: LINDENTHALER, WERNER
To: MED-EL ELEKTROMEDIZINISCHE GERAETE GMBH
Reel/Frame 032987/0740 →
Change of Name May 4, 2015
From: BIOGEN IDEC MA INC.
To: BIOGEN MA INC.
Reel/Frame 035571/0926 →
Assignment of Assignor's Interest Apr 3, 2017
From: NSGENE A/S
To: GLORIANA THERAPEUTICS, SARL
Reel/Frame 042144/0226 →
Assignment of Assignor's Interest Apr 3, 2017
From: NSGENE A/S
To: GLORIANA THERAPEUTICS, SARL
Reel/Frame 041835/0558 →
Assignment of Assignor's Interest Apr 3, 2017
From: NSGENE A/S
To: GLORIANA THERAPEUTICS,SARL
Reel/Frame 041835/0546 →
Assignment of Assignor's Interest Apr 6, 2017
From: BIOGEN MA INC.
To: GLORIANA THERAPEUTICS SARL
Reel/Frame 041887/0117 →
Assignment of Assignor's Interest Apr 27, 2017
From: BIOGEN MA INC.
To: GLORIANA THERAPEUTICS SARL
Reel/Frame 042165/0524 →
Change of Name Apr 27, 2017
From: BIOGEN IDEC MA INC.
To: BIOGEN MA INC.
Reel/Frame 042348/0303 →
Assignment of Assignor's Interest Apr 26, 2019
From: GLORIANA THERAPEUTICS SARL
To: GLORIANA THERAPEUTICS, INC.
Reel/Frame 049005/0877 →
Assignment of Assignor's Interest Nov 6, 2019
From: NSGENE A/S
To: GLORIANA THERAPEUTICS SARL
Reel/Frame 050932/0107 →
Assignment of Assignor's Interest Nov 6, 2019
From: WAHLBERG, LARS ULRIK; TORNOE, JENS
To: NSGENE A/S
Reel/Frame 050932/0067 →
Assignment of Assignor's Interest Aug 3, 2022
From: GLORIANA THERAPEUTICS, SARL
To: GLORIANA THERAPEUTICS, INC.
Reel/Frame 060711/0006 →
Assignment of Assignor's Interest Aug 3, 2022
From: GLORIANA THERAPEUTICS, INC.
To: SINFONIA BIOTHERAPEUTICS AB
Reel/Frame 060711/0374 →
Assignment of Assignor's Interest Aug 5, 2022
From: GLORIANA THERAPEUTICS, SARL
To: GLORIANA THERAPEUTICS, INC.
Reel/Frame 060727/0727 →